Usefulness of Fasting Blood Glucose to Predict Vascular Outcomes Among Individuals Without Diabetes Mellitus (from the Northern Manhattan Study)

Kazuo Eguchi, Bernadette Boden-Albala, Zhezhen Jin, Marco R. Di Tullio, Tatjana Rundek, Carlos J. Rodriguez, Shunichi Homma, Ralph L Sacco

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

It is still controversial whether fasting blood glucose (FBG) is associated with the risk of vascular outcomes among nondiabetic subjects. We sought to determine whether FBG is associated with vascular outcomes and whether this association differs among various racial or ethnic groups. In the Northern Manhattan Study, a total of 2,372 subjects (mean age 68.8 ± 10.7 years, 36% men) without a history of diabetes mellitus, stroke, or myocardial infarction (MI) were followed for an average of 7.5 years for ischemic stroke, MI, and combined vascular events defined as either ischemic stroke, MI, or vascular death. Cox proportional-hazards models were used to calculate hazard ratios and 95% confidence intervals (CIs) of FBG-associated risk for vascular outcomes after adjusting for age, gender, race/ethnicity, education, body mass index, hypertension, current smoking, previous coronary artery disease, low-density lipoprotein cholesterol, alcohol intake, and physical activity. The incidences of MI, ischemic stroke, and combined vascular events were 5.5, 6.3, and 20.0 per 1,000 person-years, respectively. Each SD increase of FBG (27 mg/dl) was associated with statistically significantly increased risks of combined vascular events (hazard ratio 1.20, 95% CI 1.09 to 1.31) and MI (hazard ratio 1.21, 95% CI 1.02 to 1.44), but the effect was weaker, evident for ischemic stroke (hazard ratio 1.13, 95% CI 0.95 to 1.34). FBG was significantly associated with incident ischemic stroke among African-American subjects (hazard ratio 1.38, 95% CI 1.09 to 1.74) and incident MI among Hispanic subjects (hazard ratio 1.24, 95% CI 0.99 to 1.55). In conclusion, FBG was an independent predictor for vascular outcomes among individuals without history of diabetes from this multiethnic cohort. The effects were more apparent for MI than for ischemic stroke; however, FBG was a strong predictor of ischemic stroke among African-American subjects.

Original languageEnglish
Pages (from-to)1404-1409
Number of pages6
JournalAmerican Journal of Cardiology
Volume100
Issue number9
DOIs
StatePublished - Nov 1 2007

Fingerprint

Blood Vessels
Blood Glucose
Fasting
Diabetes Mellitus
Stroke
Myocardial Infarction
Confidence Intervals
African Americans
Hispanic Americans
Proportional Hazards Models
Ethnic Groups
LDL Cholesterol
Coronary Artery Disease
Body Mass Index
Smoking
Alcohols
Exercise
Hypertension
Education
Incidence

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Usefulness of Fasting Blood Glucose to Predict Vascular Outcomes Among Individuals Without Diabetes Mellitus (from the Northern Manhattan Study). / Eguchi, Kazuo; Boden-Albala, Bernadette; Jin, Zhezhen; Di Tullio, Marco R.; Rundek, Tatjana; Rodriguez, Carlos J.; Homma, Shunichi; Sacco, Ralph L.

In: American Journal of Cardiology, Vol. 100, No. 9, 01.11.2007, p. 1404-1409.

Research output: Contribution to journalArticle

Eguchi, Kazuo ; Boden-Albala, Bernadette ; Jin, Zhezhen ; Di Tullio, Marco R. ; Rundek, Tatjana ; Rodriguez, Carlos J. ; Homma, Shunichi ; Sacco, Ralph L. / Usefulness of Fasting Blood Glucose to Predict Vascular Outcomes Among Individuals Without Diabetes Mellitus (from the Northern Manhattan Study). In: American Journal of Cardiology. 2007 ; Vol. 100, No. 9. pp. 1404-1409.
@article{3a9ea66842ea41528f96706a19ae559a,
title = "Usefulness of Fasting Blood Glucose to Predict Vascular Outcomes Among Individuals Without Diabetes Mellitus (from the Northern Manhattan Study)",
abstract = "It is still controversial whether fasting blood glucose (FBG) is associated with the risk of vascular outcomes among nondiabetic subjects. We sought to determine whether FBG is associated with vascular outcomes and whether this association differs among various racial or ethnic groups. In the Northern Manhattan Study, a total of 2,372 subjects (mean age 68.8 ± 10.7 years, 36{\%} men) without a history of diabetes mellitus, stroke, or myocardial infarction (MI) were followed for an average of 7.5 years for ischemic stroke, MI, and combined vascular events defined as either ischemic stroke, MI, or vascular death. Cox proportional-hazards models were used to calculate hazard ratios and 95{\%} confidence intervals (CIs) of FBG-associated risk for vascular outcomes after adjusting for age, gender, race/ethnicity, education, body mass index, hypertension, current smoking, previous coronary artery disease, low-density lipoprotein cholesterol, alcohol intake, and physical activity. The incidences of MI, ischemic stroke, and combined vascular events were 5.5, 6.3, and 20.0 per 1,000 person-years, respectively. Each SD increase of FBG (27 mg/dl) was associated with statistically significantly increased risks of combined vascular events (hazard ratio 1.20, 95{\%} CI 1.09 to 1.31) and MI (hazard ratio 1.21, 95{\%} CI 1.02 to 1.44), but the effect was weaker, evident for ischemic stroke (hazard ratio 1.13, 95{\%} CI 0.95 to 1.34). FBG was significantly associated with incident ischemic stroke among African-American subjects (hazard ratio 1.38, 95{\%} CI 1.09 to 1.74) and incident MI among Hispanic subjects (hazard ratio 1.24, 95{\%} CI 0.99 to 1.55). In conclusion, FBG was an independent predictor for vascular outcomes among individuals without history of diabetes from this multiethnic cohort. The effects were more apparent for MI than for ischemic stroke; however, FBG was a strong predictor of ischemic stroke among African-American subjects.",
author = "Kazuo Eguchi and Bernadette Boden-Albala and Zhezhen Jin and {Di Tullio}, {Marco R.} and Tatjana Rundek and Rodriguez, {Carlos J.} and Shunichi Homma and Sacco, {Ralph L}",
year = "2007",
month = "11",
day = "1",
doi = "10.1016/j.amjcard.2007.06.032",
language = "English",
volume = "100",
pages = "1404--1409",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Usefulness of Fasting Blood Glucose to Predict Vascular Outcomes Among Individuals Without Diabetes Mellitus (from the Northern Manhattan Study)

AU - Eguchi, Kazuo

AU - Boden-Albala, Bernadette

AU - Jin, Zhezhen

AU - Di Tullio, Marco R.

AU - Rundek, Tatjana

AU - Rodriguez, Carlos J.

AU - Homma, Shunichi

AU - Sacco, Ralph L

PY - 2007/11/1

Y1 - 2007/11/1

N2 - It is still controversial whether fasting blood glucose (FBG) is associated with the risk of vascular outcomes among nondiabetic subjects. We sought to determine whether FBG is associated with vascular outcomes and whether this association differs among various racial or ethnic groups. In the Northern Manhattan Study, a total of 2,372 subjects (mean age 68.8 ± 10.7 years, 36% men) without a history of diabetes mellitus, stroke, or myocardial infarction (MI) were followed for an average of 7.5 years for ischemic stroke, MI, and combined vascular events defined as either ischemic stroke, MI, or vascular death. Cox proportional-hazards models were used to calculate hazard ratios and 95% confidence intervals (CIs) of FBG-associated risk for vascular outcomes after adjusting for age, gender, race/ethnicity, education, body mass index, hypertension, current smoking, previous coronary artery disease, low-density lipoprotein cholesterol, alcohol intake, and physical activity. The incidences of MI, ischemic stroke, and combined vascular events were 5.5, 6.3, and 20.0 per 1,000 person-years, respectively. Each SD increase of FBG (27 mg/dl) was associated with statistically significantly increased risks of combined vascular events (hazard ratio 1.20, 95% CI 1.09 to 1.31) and MI (hazard ratio 1.21, 95% CI 1.02 to 1.44), but the effect was weaker, evident for ischemic stroke (hazard ratio 1.13, 95% CI 0.95 to 1.34). FBG was significantly associated with incident ischemic stroke among African-American subjects (hazard ratio 1.38, 95% CI 1.09 to 1.74) and incident MI among Hispanic subjects (hazard ratio 1.24, 95% CI 0.99 to 1.55). In conclusion, FBG was an independent predictor for vascular outcomes among individuals without history of diabetes from this multiethnic cohort. The effects were more apparent for MI than for ischemic stroke; however, FBG was a strong predictor of ischemic stroke among African-American subjects.

AB - It is still controversial whether fasting blood glucose (FBG) is associated with the risk of vascular outcomes among nondiabetic subjects. We sought to determine whether FBG is associated with vascular outcomes and whether this association differs among various racial or ethnic groups. In the Northern Manhattan Study, a total of 2,372 subjects (mean age 68.8 ± 10.7 years, 36% men) without a history of diabetes mellitus, stroke, or myocardial infarction (MI) were followed for an average of 7.5 years for ischemic stroke, MI, and combined vascular events defined as either ischemic stroke, MI, or vascular death. Cox proportional-hazards models were used to calculate hazard ratios and 95% confidence intervals (CIs) of FBG-associated risk for vascular outcomes after adjusting for age, gender, race/ethnicity, education, body mass index, hypertension, current smoking, previous coronary artery disease, low-density lipoprotein cholesterol, alcohol intake, and physical activity. The incidences of MI, ischemic stroke, and combined vascular events were 5.5, 6.3, and 20.0 per 1,000 person-years, respectively. Each SD increase of FBG (27 mg/dl) was associated with statistically significantly increased risks of combined vascular events (hazard ratio 1.20, 95% CI 1.09 to 1.31) and MI (hazard ratio 1.21, 95% CI 1.02 to 1.44), but the effect was weaker, evident for ischemic stroke (hazard ratio 1.13, 95% CI 0.95 to 1.34). FBG was significantly associated with incident ischemic stroke among African-American subjects (hazard ratio 1.38, 95% CI 1.09 to 1.74) and incident MI among Hispanic subjects (hazard ratio 1.24, 95% CI 0.99 to 1.55). In conclusion, FBG was an independent predictor for vascular outcomes among individuals without history of diabetes from this multiethnic cohort. The effects were more apparent for MI than for ischemic stroke; however, FBG was a strong predictor of ischemic stroke among African-American subjects.

UR - http://www.scopus.com/inward/record.url?scp=35348826235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35348826235&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2007.06.032

DO - 10.1016/j.amjcard.2007.06.032

M3 - Article

VL - 100

SP - 1404

EP - 1409

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 9

ER -